0001171843-21-004627.txt : 20210630
0001171843-21-004627.hdr.sgml : 20210630
20210630165010
ACCESSION NUMBER: 0001171843-21-004627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210630
DATE AS OF CHANGE: 20210630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Robert
CENTRAL INDEX KEY: 0001815574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38298
FILM NUMBER: 211062534
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA CORP.
STREET 2: 100 PHOENIX DRIVE, SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zomedica Corp.
CENTRAL INDEX KEY: 0001684144
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: (734) 369-2555
MAIL ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: Zomedica Pharmaceuticals Corp.
DATE OF NAME CHANGE: 20160908
4
1
ownership.xml
X0306
4
2021-06-30
0
0001684144
Zomedica Corp.
ZOM
0001815574
Cohen Robert
C/O ZOMEDICA CORP.
100 PHOENIX DRIVE, SUITE 125
ANN ARBOR
MI
48108
1
1
0
0
CEO
Common Stock, without par value
2021-06-30
4
M
0
543750
0.23
A
543750
D
Common Stock, without par value
2021-06-30
4
S
0
543750
0.8227
D
0
D
Stock option (right to buy)
0.23
2021-06-30
4
M
0
543750
0
D
2030-12-30
Common Stock, without par value
543750
10262500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.815 to $0.845 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.
/s/ John Hogoboom, attorney-in-fact
2021-06-30